Chronic Musculoskeletal Pain
Conditions
Keywords
Complementary Therapies, Chronic Pain, Integrative Medicine, Chiropractic, Acupuncture, Yoga, Tai Chi, Meditation, Therapeutic Massage, Qigong, Complementary and Integrative Health
Brief summary
The APPROACH Study (Assessing Pain, Patient-Reported Outcomes and Complementary and Integrative Health) assesses the effects of use of practitioner-delivered CIH therapies alone compared to the combination of self-care and practitioner-delivered CIH therapies among Veterans with chronic musculoskeletal pain. The APPROACH study is predominately conducting a secondary analysis of patient-reported data being collected by the Veterans Health Administration's (VA) Office of Patient Centered Care and Cultural Transformation among Veterans receiving care at one of 18 VA medical centers. Those 18 facilities received funding to expand availability of CIH therapies as part of the Comprehensive Addiction and Recovery Act of 2016. That patient-reported data is being supplemented with VA electronic health record data and data on the 18 medical centers' business practices (nudges, the instrumental variable). Practitioner-delivered therapies under study include chiropractic care, acupuncture, and therapeutic massage; self-care therapies include Tai Chi/Qigong, yoga, and meditation. The primary outcomes are improvement in pain severity and pain interference, assessed using the Brief Pain Inventory (BPI), six months after initiating CIH therapies compared to baseline. Patients will enter treatment groups based on the CIH therapies they use, as randomizing patients to specific therapies would require withholding therapies routinely offered at VA. The investigators will address selection bias and confounding by using sites' variations in business practices and other encouragements (nudges) to receiving different CIH therapies as a surrogate for direct randomization using instrumental variables econometric methods.
Detailed description
Design: The investigators are employing a quasi-experimental encouragement study design in which subjects are able to choose their own CIH therapies, but some are offered extra encouragements (nudges) to choose specific CIH therapies. Instead of being randomized to a CIH therapy, individuals will enter one of three study groups - Veterans Using Practitioner Delivered CIH Therapies Only, Veterans Using Self-Care CIH Therapies Only, or Veterans Using a Combination of Practitioner-Delivered and Self-Care CIH Therapies (Dual-Care) - based on what CIH therapies they used six months after they initiate any CIH therapy. Although accrual to study group is not random, some sites have strong business practices/nudges that lead to considerable variation in which CIH therapies patients use. The variation induced by these business practices/nudges provides a quasi-experimental natural experiment that can be assessed through an instrumental variables analytic approach. The purpose of using business practices as an instrument for accruing patients to treatment groups, similar to the use of randomization, is to reduce potential selection and confounding bias. The six-month treatment window will allow for patients to initiate one type of CIH therapy and add additional CIH therapies based on business practices/nudges at their site within the evaluation period. The CIH therapies that patients receive will be as they are delivered by the 18 VHA Whole Health flagship study sites and community care practices. The APPROACH study was initially envisioned to examine primary and secondary outcomes for the above-named three study groups. Due to the study's pragmatic design and sampling approach, the sample size of the Veterans Using Self-Care CIH Therapies Only group did not meet the minimum threshold necessary to detect between-group differences of interest. It was therefore determined that study revisions would be necessary. Sites: The study sites are the VA's 18 Whole Health Flagship sites: VA Boston Health Care System, VA New Jersey Health Care System, Erie VAMC, Beckley VAMC, W. G. (Bill) Hefner VAMC, Atlanta VAMC, Tampa VAMC, Tennessee Valley Health Care System, Aleda E. Lutz VAMC, Tomah VAMC, St. Louis VA Health Care System, Central Arkansas Veterans Healthcare System, South Texas Veterans Health Care System, Salt Lake City VAMC, VA Portland Health Care System, Palo Alto VAMC, Tucson VAMC, VA Nebraska-Western Iowa Health Care System). Secondary Data from the VA Office of Patient Centered Care and Cultural Transformation's Complementary and Integrative Health Therapy Patient Experience Survey: The APPROACH study is predominately conducting a secondary analysis of patient-reported data being collected by VA OPCC&CT's four timepoint survey (baseline and months 1, 3, 6). Almost all of the outcomes listed below are from that survey.
Interventions
Practitioner-delivered CIH therapies (acupuncture, therapeutic massage, chiropractic care) as received in VHA and community practice settings
Combination of practitioner-delivered (acupuncture, therapeutic massage, chiropractic care) and self-care (Tai Chi/Qigong, yoga, meditation) CIH therapies as received in VHA and community practice settings
Veterans using self-care (yoga, meditation, Tai Chi, Qi Gong) CIH therapies only, as received in VHA and community practice settings
Sponsors
Study design
Eligibility
Inclusion criteria
* Veteran * History of (chronic) musculoskeletal-related pain conditions recorded in the EHR in the year prior to the index visit, and self-report pain present every day or nearly every day for 3 months from the CIH index visit using an eligibility screener * Aged 18-89 on index CIH visit date
Exclusion criteria
* Diagnoses of serious mental illness in the year prior to initiating CIH * History of spinal cord injury * Hospitalization 30 days prior to initiating CIH * Recorded CIH use in the EHR in the 6 months prior to the index CIH visit and reported CIH use in the 8 weeks prior to index CIH visit
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Brief Pain Inventory (BPI) Severity Scale | Change from baseline to 6 months | Measure of pain severity. Scores range from 0-10, with higher scores indicating more severe pain. |
| Brief Pain Inventory (BPI) Interference Scale | Change from baseline to 6 months | Measure of pain-related functional interference. Scores range from 0-10, with higher scores indicating greater pain-related functional interference. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient Global Impression of Change (PGIC) for Improvement in Pain | 6 months | Single-item scale which assesses how much a patient perceives their pain has improved following a specified intervention. Item rated on a 5-point scale ranging from 1 to 5, with 1 being "much better" and 5 being "much worse". Higher scores represent worse pain outcomes following the specified intervention. |
| Patient Global Impression of Change (PGIC) for Improvement in Mental Health | 6 months | Single-item scale which assesses how much a patient perceives their mental health has improved following a specified intervention. Item rated on a 5-point scale ranging from 1 to 5, with 1 being "much better" and 5 being "much worse". Higher scores represent worse mental health outcomes following the specified intervention. |
| Patient Global Impression of Change (PGIC) for Improvement in Fatigue | 6 months | Single-item scale which assesses how much a patient perceives their fatigue has improved following a specified intervention. Item rated on a 5-point scale ranging from 1 to 5, with 1 being "much better" and 5 being "much worse". Higher scores represent worse fatigue outcomes following the specified intervention. |
| Patient Global Impression of Change (PGIC) for Improvement in Overall Well-being | 6 months | Single-item scale which assesses how much a patient perceives their overall well-being has improved following a specified intervention. Item rated on a 5-point scale ranging from 1 to 5, with 1 being "much better" and 5 being "much worse". Higher scores represent worse overall well-being outcomes following the specified intervention. |
| PROMIS10 Global Assessment of Physical Health | Change from baseline to 6 months | Assesses physical function, fatigue, pain, and social health; score derived from the PROMIS10 Global Health measure which assesses physical and mental health and generates two summary scores: Global Physical Health and Global Mental Health. Scores are reported on a T-score metric wherein the mean score of the general population is standardized to 50 with a standard deviation of 10. A score of 50 indicates average physical health, as compared to the general population. Higher scores indicate better physical health. |
| PROMIS10 Global Assessment of Mental Health | Change from baseline to 6 months | Assesses emotional distress and mental health; score derived from the PROMIS10 Global Health measure which assesses physical and mental health and generates two summary scores: Global Physical Health and Global Mental Health. Scores are reported on a T-score metric wherein the mean score of the general population is standardized to 50 with a standard deviation of 10. A score of 50 indicates average mental health, as compared to the general population. Higher scores indicate better mental health. |
| Life Engagement Test (LET) | Change from baseline to 6 months | 6 items are rated on a 5-point Likert scale ranging from 1 to 5. Scores range from 6 to 30, with higher scores indicating better life engagement/purpose in life. |
| Perceived Stress Scale (PSS-4) | Change from baseline to 6 months | Measure of perceived stress consisting of 4 items which are each rated on a 5-point scale ranging from 0 to 4. Scores range from 0 to 16, with higher scores indicating greater perceived stress. |
| Patient Health Questionnaire (PHQ2) | Change from baseline to 6 months | Measure of depressed mood and anhedonia consisting of 2 items which are each rated on a 7-point scale ranging from 0 to 6. Scores range from 0 to 12, with higher scores indicating more depressive symptoms. |
Countries
United States
Contacts
VA Greater Los Angeles Healthcare System, Sepulveda, CA
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 57 Years STANDARD_DEVIATION 14 |
| Distance to Nearest Primary Care Site 2 miles or less | 114 Participants |
| Distance to Nearest Primary Care Site 2 to 15 miles | 175 Participants |
| Distance to Nearest Primary Care Site Greater than 15 miles | 527 Participants |
| Distance to Nearest Primary Care Site Unknown | 21 Participants |
| Elixhauser Comorbidity Index | 4.8 units on a scale STANDARD_DEVIATION 3 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 172 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 1357 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 74 Participants |
| Mental Health Conditions Anxiety | 1847 Participants |
| Mental Health Conditions Depression | 801 Participants |
| Mental Health Conditions PTSD | 179 Participants |
| Mental Health Service in Past 30 Days | 996 Participants |
| Opioid Use during Prior 90 Days New Opioid Prescription | 61 Participants |
| Opioid Use during Prior 90 Days None | 2648 Participants |
| Opioid Use during Prior 90 Days Ongoing Opioid Prescription | 417 Participants |
| Opioid Use during Prior 90 Days Recently Quit | 399 Participants |
| Pain Clinic Visit in Past 30 Days | 48 Participants |
| Pain Type Back Pain | 2642 Participants |
| Pain Type Fibromyalgia | 19 Participants |
| Pain Type Joint Pain | 234 Participants |
| Pain Type Musculoskeletal Chest Pain | 42 Participants |
| Pain Type Neck Pain | 96 Participants |
| Pain Type Other Pain | 483 Participants |
| Physical Therapy Use in Past 30 Days | 278 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 19 Participants |
| Race (NIH/OMB) Asian | 1 Participants |
| Race (NIH/OMB) Black or African American | 347 Participants |
| Race (NIH/OMB) More than one race | 37 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 17 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 89 Participants |
| Race (NIH/OMB) White | 193 Participants |
| Region of Enrollment United States | 1618 Participants |
| Service-Connected Percentage 50% or more | 230 Participants |
| Service-Connected Percentage Less than 50% | 67 Participants |
| Sex: Female, Male Female | 438 Participants |
| Sex: Female, Male Male | 1180 Participants |
| Smoking Status Current smoker | 402 Participants |
| Smoking Status Former smoker | 97 Participants |
| Smoking Status Never smoker | 117 Participants |
| Smoking Status Unknown | 18 Participants |
| Whole Health Use in Past 30 Days | 227 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 | 0 / 0 |